| Description | Lanatoside C (Ceglunate) is a cardiac glycoside, a type of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia (irregular heartbeat). Lanatoside C can be used orally or by the intravenous route. |
| Target activity | DENV (HuH-7 cells):0.19 μM |
| Synonyms | Cedilanid, Ceglunate, Isolanid, 毛花甙丙, 毛花苷C |
| molecular weight | 985.12 |
| Molecular formula | C49H76O20 |
| CAS | 17575-22-3 |
| Storage | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 13 mg/mL (13.2 mM) |
| References | 1. Lypka A, Lazowski J. Wiad Lek. 1979 Sep 15;32(18):1277-81. 2. Hu Y, Yu K, Wang G, et al. Lanatoside C inhibits cell proliferation and induces apoptosis through attenuating Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell[J]. Biochemical pharmacology. 2018 Apr;150:280-292. |